Clinical and laboratory evaluation of different dosage forms of baneocin for the treatment of wound infection

Khirurgiia (Mosk). 2009:(9):59-65.

Authors

L A Blatun, A O Zhukov, Iu A Amiraslanov, R P Terekhova, V A Agafonov, N G Askerov, V A Malina, A A Ushakov, A P Ivanov, S V Fedotov, A A Pechetov, A B Tertitskaia

PMID: 19824200

No abstract available

Publication types

Comparative Study

MeSH terms

Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use
Bacitracin / administration & dosage*
Bacitracin / therapeutic use
Dose-Response Relationship, Drug
Drug Combinations
Female
Gram-Negative Bacteria / drug effects
Gram-Negative Bacteria / isolation & purification*
Gram-Negative Bacterial Infections / drug therapy
Gram-Negative Bacterial Infections / microbiology
Gram-Positive Bacteria / drug effects
Gram-Positive Bacteria / isolation & purification*
Gram-Positive Bacterial Infections / drug therapy
Gram-Positive Bacterial Infections / microbiology
Humans
Male
Middle Aged
Neomycin / administration & dosage*
Neomycin / therapeutic use
Surgical Wound Infection / drug therapy*
Surgical Wound Infection / microbiology
Treatment Outcome
Wound Healing / drug effects*
Young Adult

Substances

Anti-Bacterial Agents
Drug Combinations
Bacitracin
Neomycin